Asian Spectator

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

Magazine

5 evaluasi atas program bendungan era Jokowi

Presiden RI Joko Widodo (Jokowi) meresmikan Bendungan Pamukkulu, di Kabupaten Takalar, Provinsi Sulawesi Selatan.(Muchlis Jr/BPMI Setpres)Prabowo-Gibran, yang pencalonannya sebagai Presiden dan Wakil ...

Benarkah goresan kecil di tubuh bisa mematikan di masa depan? Ini kata pakar resistansi antibiotik

Ilustrasi luka gores pada jari seorang perempuan. Timofeyev Alexander/ShutterstockArtikel ini diterjemahkan dari bahasa Inggris untuk memperingati Pekan Kesadaran Antimikroba Dunia, 18-24 November.Ber...

Why Now Is the Perfect Time to Lease an Electric Vehicle?

Australia is seeing strong year on year growth of EVs, with government incentives, advancements in technology, and environmental awareness driving more people to consider electric vehicles. If you’ve...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion